Korean J Gastroenterol.  2021 Dec;78(6):362-363. 10.4166/kjg.2021.158.

Biopsy-proven Non-alcoholic Fatty Liver Disease and Incident Cancer

• Kim HY

• KMID: 2523600
• DOI: http://doi.org/10.4166/kjg.2021.158

Abstract

no abstract available.

Reference

1. Allen AM, Hicks SB, Mara KC, Larson JJ, Therneau TM. 2019; The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - a longitudinal cohort study. J Hepatol. 71:1229–1236. DOI: 10.1016/j.jhep.2019.08.018. PMID: 31470068. PMCID: PMC6921701.

2. Kim GA, Lee HC, Choe J, et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2017; Nov. 2. [Epub ahead of print]. DOI: 10.1016/j.jhep.2017.09.012. PMID: 29150142.

3. Younossi ZM, Otgonsuren M, Henry L, et al. 2015; Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 62:1723–1730. DOI: 10.1002/hep.28123. PMID: 26274335.

4. Simon TG, Roelstraete B, Sharma R, Khalili H, Hagström H, Ludvigsson JF. 2021; Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study. Hepatology. 74:2410–2423. DOI: 10.1002/hep.31845. PMID: 33811766.

5. Kanwal F, Kramer JR, Mapakshi S, et al. 2018; Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology. 155:1828–1837.e2. DOI: 10.1053/j.gastro.2018.08.024. PMID: 30144434. PMCID: PMC6279617.

6. Chacko KR, Reinus J. 2016; Extrahepatic complications of nonalcoholic fatty liver disease. Clin Liver Dis. 20:387–401. DOI: 10.1016/j.cld.2015.10.004. PMID: 27063276.